1Fujimura M,Kaneta T,Mugikura S,et al.Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset Moyamoya disease.Surgical Neurology,2007,67(3):273-282.
2Rosand J,Eckman MH,Knudsen KA,et al.The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage[J].Arch Intern Med,2004,164(8):880-884.
3Sjoblom L,Hrdemark HG,Lindgren A,et al.Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy:a Swedish multicenter study[J].Stroke,2001,32(11):2567-2574.
6Flibotte JJ,Hagan N,O'Donnell J,et al.Warfarin,hematoma expansion,and outcome of intracerebral hemorrhage[J].Neurology,2004,63(6):1059-1064.
7Joshua N,Goldstein GN,Thomas SH,et al.Timing of fresh frozen plasma administration and rapid correction of coagulopathy in Warfarin-related intracerebral hemorrhage[J].Stroke,2006,37(1):151-155.
8Yasaka M,Sakata T,Minematsu K,et al.Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication[J].Thromb Res,2002,108(1):25-30.
9Wijdicks EF,Schievink WI,Brown RD,et al.The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves[J].Neurosurgery,1998,42(4):769-773.
10Freeman WD,Aguilar MI.Management of warfarin-related intracerebral hemorrhage[J].Expert Rev Neurother,2008,8(2):271-290.
